1. Home
  2. OLN vs TMDX Comparison

OLN vs TMDX Comparison

Compare OLN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$19.10

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$88.58

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
TMDX
Founded
1892
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
OLN
TMDX
Price
$19.10
$88.58
Analyst Decision
Hold
Buy
Analyst Count
13
9
Target Price
$25.23
$148.22
AVG Volume (30 Days)
3.2M
969.9K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.61
Revenue
$6,780,800,000.00
$605,494,000.00
Revenue This Year
$2.57
$24.25
Revenue Next Year
$3.51
$18.75
P/E Ratio
N/A
$146.95
Revenue Growth
3.68
37.13
52 Week Low
$17.73
$60.11
52 Week High
$30.46
$156.00

Technical Indicators

Market Signals
Indicator
OLN
TMDX
Relative Strength Index (RSI) 39.41 64.49
Support Level $18.54 $66.64
Resistance Level $21.41 $152.95
Average True Range (ATR) 0.86 4.31
MACD -0.07 1.16
Stochastic Oscillator 26.11 92.03

Price Performance

Historical Comparison
OLN
TMDX

About OLN Olin Corporation

Olin was founded in 1892 and has been publicly listed since 1917. The company has a unique dual identity compared with some of its chemical peers: it is the world's largest chlor-alkali producer by capacity, and it owns the Winchester brand, a leading US ammunition manufacturer. Olin has three reportable segments: chlor-alkali products and vinyls (CAPV or CAP), Epoxies, and Winchester, which represent around 55%, 20%, and 25% of sales, respectively.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: